Transcriptional Control of Human Cytomegalovirus Latency
人类巨细胞病毒潜伏期的转录控制
基本信息
- 批准号:10370328
- 负责人:
- 金额:$ 36.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-11 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAffectAmino Acid MotifsAntiviral AgentsBrain GlioblastomaBrain NeoplasmsCREB1 geneCardiovascular DiseasesCell Differentiation processCellsClinicalCommunicable DiseasesComplexCongenital AbnormalityCytomegalovirusDataDetectionDiseaseEarly PromotersElderlyElementsEpigenetic ProcessEventGene SilencingGenetic TranscriptionGenomeGlycoproteinsGolgi ApparatusHeterochromatinHistone DeacetylaseHumanImmuneImmune mediated destructionImmunityImmunologic SurveillanceInfectionInstitutesLengthLysineLyticLytic PhaseMalignant NeoplasmsMediatingMedicalModificationMyeloid CellsOrgan TransplantationPathway interactionsPersonsPhaseProcessProductionProteinsPublishingRoleSignal TransductionStructureTherapeutic EffectTimeTranscriptional RegulationUndifferentiatedViralVirusWorkactivating transcription factorfightinggene repressionhistone methylationnovelprematurepreventpromoterreactivation from latencyrecruitsuccesstranscription factor
项目摘要
Abstract
Latency permits human cytomegalovirus (HCMV) to colonize its hosts for their lifetime by avoiding
immune detection and clearance. The abilities of the virus to persist latently and reactivate productively are
major factors in the serious medical issues caused by HCMV infections. HCMV is latent in undifferentiated
myeloid cells and reactivates when these cells differentiate. The Immediate Early 1 (IE1) protein is a
transcription factor that promotes progression through the viral lytic phase. During latency the levels of lytic
(productive) phase proteins such as IE1 are kept extremely low (or completely absent) because the
promoter that drives its expression, the Major Immediate Early Promoter (MIEP) is transcriptionally silenced
by heterochromatin. Premature triggering of the lytic cycle in undifferentiated myeloid cells by spurious
production of proteins like IE1 likely results in immune destruction of the reactivating cell before HCMV can
complete a productive round of replication. Keeping full length IE1 protein levels low or absent protects
latently infected cells from immune surveillance and restricts reactivation events until the cell differentiates.
Our lab demonstrated the cellular protein Daxx and an associated histone deacetylase (HDAC) silences the
MIEP when HCMV establishes latency. Likewise, we also published that the viral UL138 protein silences
IE1 transcription during latency by inhibiting the recruitment of lysine-specific demethylases
(KDMs) to the MIEP that remove repressive epigenetic histone methylations to activate transcription. In
Aim 1, we propose to define how UL138 prevents KDM recruitment to the MIEP and silences IE1
transcription during latency from its localization at the Golgi apparatus. Deletion of UL138 from the HCMV
genome revealed that at least one more suppressor of IE1 transcription is encoded by clinical strains. Such
functional redundancy in silencing the MIEP underscores the importance of this process for the worldwide
success of HCMV. We have now identified this novel silencer of IE transcription. In Aim 2 we propose
to determine how it represses the MIEP during latency. Knowing how the MIEP is silenced during latency
should reveal mechanisms through which IE1 transcription can be controlled to either inhibit or induce
reactivation from latency for therapeutic effect.
抽象的
潜伏期允许人类巨细胞病毒(HCMV)通过避免避免
免疫检测和清除。该病毒的能力持续存在,有效地重新激活
HCMV感染引起的严重医疗问题的主要因素。 HCMV潜在未分化
当这些细胞分化时,髓样细胞并重新激活。立即1(IE1)蛋白是一种
转录因子通过病毒裂解阶段促进进展。在延迟期间裂解水平
(生产性的)相蛋白(例如IE1)保持极低(或完全不存在),因为
驱动其表达的启动子,主要的早期启动子(MIEP)是转录沉默的
通过异染色质。未分化的髓样细胞中的裂解周期过早触发。
像IE1这样的蛋白质的产生可能会导致重新激活细胞的免疫破坏HCMV可以
完成一轮复制。保持全长IE1蛋白水平低或不存在保护
从免疫监测中延迟感染的细胞并限制重新激活事件,直到细胞区分。
我们的实验室证明了细胞蛋白DAXX和相关的组蛋白脱乙酰基酶(HDAC)沉默
MIEP当HCMV建立延迟时。同样,我们还发表了病毒UL138蛋白质静音
通过抑制赖氨酸特异性去甲基酶的募集,IE1转录在潜伏期期间的转录
(KDM)到MIEP,去除抑制性表观遗传组蛋白甲基化以激活转录。在
AIM 1,我们建议定义UL138如何防止KDM招募到MIEP和沉默IE1
潜伏期在高尔基体设备的延迟期间的转录。从HCMV中删除UL138
基因组表明,IE1转录的至少一个抑制剂由临床菌株编码。这样的
沉默MIEP的功能冗余强调了这一过程在全球范围内的重要性
HCMV的成功。现在,我们已经确定了这种新颖的IE转录消音器。在AIM 2中我们建议
确定其在延迟期间如何抑制MIEP。知道在延迟期间如何沉默MIEP
应揭示可以控制IE1转录以抑制或诱导的机制
从潜伏期的治疗作用中重新激活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT F KALEJTA其他文献
ROBERT F KALEJTA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT F KALEJTA', 18)}}的其他基金
Deciphering the cell type specific control of HCMV tegument-delivered pp71 subcellular localization
破译 HCMV 皮膜传递的 pp71 亚细胞定位的细胞类型特异性控制
- 批准号:
10176409 - 财政年份:2020
- 资助金额:
$ 36.98万 - 项目类别:
Transcriptional Control of Human Cytomegalovirus Latency
人类巨细胞病毒潜伏期的转录控制
- 批准号:
9894713 - 财政年份:2018
- 资助金额:
$ 36.98万 - 项目类别:
Evading innate immunity during human cytomegalovirus latency
在人类巨细胞病毒潜伏期逃避先天免疫
- 批准号:
9919503 - 财政年份:2018
- 资助金额:
$ 36.98万 - 项目类别:
Transcriptional Control of Human Cytomegalovirus Latency
人类巨细胞病毒潜伏期的转录控制
- 批准号:
9447725 - 财政年份:2018
- 资助金额:
$ 36.98万 - 项目类别:
Evading innate immunity during human cytomegalovirus latency
在人类巨细胞病毒潜伏期逃避先天免疫
- 批准号:
10392335 - 财政年份:2018
- 资助金额:
$ 36.98万 - 项目类别:
Transcriptional Control of Human Cytomegalovirus Latency
人类巨细胞病毒潜伏期的转录控制
- 批准号:
10132969 - 财政年份:2018
- 资助金额:
$ 36.98万 - 项目类别:
Retinoblastoma (Rb) protein pathway in human cytomegalovirus infected cells
人巨细胞病毒感染细胞中的视网膜母细胞瘤 (Rb) 蛋白途径
- 批准号:
8259782 - 财政年份:2010
- 资助金额:
$ 36.98万 - 项目类别:
Retinoblastoma (Rb) protein pathway in human cytomegalovirus infected cells
人巨细胞病毒感染细胞中的视网膜母细胞瘤 (Rb) 蛋白途径
- 批准号:
7984157 - 财政年份:2010
- 资助金额:
$ 36.98万 - 项目类别:
Retinoblastoma (Rb) protein pathway in human cytomegalovirus infected cells
人巨细胞病毒感染细胞中视网膜母细胞瘤 (Rb) 蛋白途径
- 批准号:
8651405 - 财政年份:2010
- 资助金额:
$ 36.98万 - 项目类别:
Retinoblastoma (Rb) protein pathway in human cytomegalovirus infected cells
人巨细胞病毒感染细胞中的视网膜母细胞瘤 (Rb) 蛋白途径
- 批准号:
8066409 - 财政年份:2010
- 资助金额:
$ 36.98万 - 项目类别:
相似国自然基金
TiC-TiB2颗粒喷射成形原位合成及其对M2高速工具钢共晶碳化物形成与演化的影响
- 批准号:52361020
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
植被群落演替对河道水流结构和纵向离散特性影响机制研究
- 批准号:52309088
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
热带印度洋海表皮温日变化的数值模拟及对海气热通量的影响
- 批准号:42376002
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
协同遥感和气候模型的城市高温热浪时空特征及其对热暴露影响研究
- 批准号:42371397
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
相似海外基金
Transcriptional Control of Human Cytomegalovirus Latency
人类巨细胞病毒潜伏期的转录控制
- 批准号:
9894713 - 财政年份:2018
- 资助金额:
$ 36.98万 - 项目类别:
Transcriptional Control of Human Cytomegalovirus Latency
人类巨细胞病毒潜伏期的转录控制
- 批准号:
9447725 - 财政年份:2018
- 资助金额:
$ 36.98万 - 项目类别:
Transcriptional Control of Human Cytomegalovirus Latency
人类巨细胞病毒潜伏期的转录控制
- 批准号:
10132969 - 财政年份:2018
- 资助金额:
$ 36.98万 - 项目类别:
Functional Map -- HIV Tat Second Exon in Cytokine Regulation
功能图谱——细胞因子调控中的 HIV Tat 第二外显子
- 批准号:
7629038 - 财政年份:
- 资助金额:
$ 36.98万 - 项目类别:
Functional Map -- HIV Tat Second Exon in Cytokine Regulation
功能图谱——细胞因子调控中的 HIV Tat 第二外显子
- 批准号:
7475923 - 财政年份:
- 资助金额:
$ 36.98万 - 项目类别: